Mark Roithmayr
@TheADDFCEO
Followers
101
Following
48
Media
6
Statuses
39
Proudly stewarding the @theADDF to solve for #Alzheimers. Husband, Father and Grandpa. Arsenal enthusiast. Opinions are my own.
New York City
Joined June 2024
Brilliant conversation!.
🎙️#Biotech2050 host @aloktayi chats with @a_hfillit & @TheADDFCEO of @TheADDF on how they’re reshaping Alzheimer’s R&D—from blood tests to biotech bets. Discover how mission meets innovation. 🎧 Listen now: #Alzheimers #DrugDiscovery #HealthcareFunding
0
0
1
⸻. I waited to post, honoring Leonard Lauder’s passing. Then Bill Gates shared this note on Alzheimer’s and the ADDF:.🔗 Leonard once told Bill:.“I’m too old to buy green bananas. Let’s start the Diagnostics Accelerator together.”. The rest is history.
0
1
2
A true loss for humanity. There will never be another Leonard Lauder.
We are deeply saddened to share the passing of ADDF Co-Founder Leonard A. Lauder. Alongside his brother, Leonard founded the ADDF in 1998, transforming the Alzheimer's research landscape through their vision, catalytic funding, venture philanthropy.
0
0
1
Congrats to Amanda for keeping the guys healthy!.
0
0
0
Brilliant survey by @alzassociation.
A new survey reveals 79% of Americans aged 45+ want to know if they're in the early stages of Alzheimer's. With new blood tests and treatments available, more are opting for early diagnosis and proactive care. @NPRjonhamilton @alzassociation @NPR .
0
0
1
A brilliant new partnership with Siemens created by an incredible partnership with Gates Ventures.
ADDF’s Diagnostics Accelerator (DxA) announced a new partnership with @SiemensHealth to license SpeechDx, a gold standard dataset for Alzheimer’s biomarker, which accelerates the development of digital diagnostics & potential for earlier detection.
0
0
3
Europe needs to act now to ensure its patients are not left behind – POLITICO
0
0
0
RT @TheADDF: "There has never been a more exciting time to be in Alzheimer’s research.”. In a recent interview with @pharmaboardroom, @TheA….
0
3
0
RT @TheADDF: A new study in @TheLancetNeuro published on March 19, suggests early anti-amyloid drugs may prevent Alzheimer’s. @washumedicin….
0
2
0
Innovation drives the field forward. Great to see @FastCompany recognize the innovation and technology @Alzpath, one of the Diagnostics Accelerator portfolio companies as one of the Most Innovative Biotech Companies of 2025!.
Congratulations to our partners @Alzpath, one of the Diagnostics Accelerator portfolio companies recognized as one of @FastCompany's Most Innovative Biotech Companies of 2025! Their blood test is revolutionizing Alzheimer's care and research.
0
1
2
An absolutely BRILLIANT evening.
ADDF's Inaugural Scientific Summit united top scientists in #Alzheimers. Daniel Skovronsky of @EliLillyandCo received the Melvin R. Goodes Prize, the Nobel Prize of Alzheimer's, & featured a panel w/@niranjanbose & an inspiring address from @drsanjaygupta
0
1
2
An incredible night at the Inaugural ADDF Scientific Summit honoring Dan Skovronsky of @EliLillyandCo with the 2025 Melvin R. Goodes Prize, the Nobel Prize of Alzheimer’s! Top researchers united & @DrSanjayGupta's inspiring talk with the determination to conquer Alzheimer’s!
0
2
3
BIG news in the Alz field.
We're thrilled to announce Daniel Skovronsky of @EliLillyandCo is the recipient of the 2025 Melvin R. Goodes Prize! Skovronsky will be recognized for his groundbreaking work to develop critical diagnostic tests and advance new treatments for Alzheimer’s
0
1
2
MSM has been writing a lot lately on Alzheimer’s. Unfortunately it has been a backwards look, stirring up a long decided ago debate on the amyloid theory. Nice to see Pharma Boardroom provide a clear view on truly where we are, and where we are headed.
0
1
2
The ‘Times they are a changing…” So great to see @EliLillyandCo and @eisaiusneuro along with novel therapeutics pioneers @a_hfillit and @DrJeffCummings joined by AD statistical expert Suzanne Hendrix opening the door to combination therapies in Alzheimer’s!.
At #CTAD24, roundtable on #combinationtherapy highlights new era of #Alzheimers, which is moving closer to a #precisionmedicine approach. Combination trials will define the next phase of therapies, helping us better understand which biological process contribute to the disease
0
2
5
The “Dream Team” of Biomarkers kicking off the ADDF Summit at #CTAD24 in Madrid this week….
What is the future of #Alzheimers #biomarkers? A panel led by @MiiaKivipelto featuring @a_hfillit, Dr. Henrik Zetterberg, @SuzanneESchind1, @CharlotteTeuni1, Dr. Jeff Cummings & Dr. Joel Braunstein speak to how Alzheimer’s biomarkers will shape #diagnosis and treatment #CTAD24
0
1
3